Using engineered gut bacteria-derived microvesicles for plague vaccines.

Carding, Simon (Principal Investigator)

Status	Finished
Effective start/end date	1/05/17 → 30/04/18

Funding

Innovate UK: £499,798.16

Use of bioengineered human commensal gut bacteria-derived microvesicles for mucosal plague vaccine delivery and immunization
Carvalho, A. L., Miquel-Clopés, A., Wegmann, U., Jones, E., Stentz, R., Telatin, A., Walker, N. J., Butcher, W. A., Brown, P. J., Holmes, S., Dennis, M. J., Williamson, E. D., Funnell, S. G. P., Stock, M. & Carding, S. R., Jun 2019, In: Clinical and Experimental Immunology. 196, 3, p. 287-304 18 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File

41 Citations (Scopus)

20 Downloads (Pure)